Article Details

DLA Piper advises Akoya Biosciences in its US$151 million initial public offering

Retrieved on: 2021-05-03 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

DLA Piper advises Akoya Biosciences in its US$151 million initial public offering. View article details on hiswai:

Excerpt

(Nasdaq: AKYA) in its recent initial public offering of 7,567,000 shares of its common stock at a price of $20 per share, including the exercise of the ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up